Protein association of the neurotoxin and non-protein amino acid BMAA (β-N-methylamino-l-alanine) in the liver and brain following neonatal administration in rats

Toxicology Letters

Volumn 226, Issue 1, 2014, Pages 1-5

  Karlsson, Oskar ^a   Jiang, Liying ^b   Andersson, Marie ^a   Ilag, Leopold L ^b   Brittebo, Eva B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

ALS PDC; Autoradiography; Cyanobacteria; Mass spectrometry; Misincorporation; N (2 aminoethyl) glycine

Indexed keywords

ALS/PDC; AUTORADIOGRAPHY; CYANOBACTERIA; MASS SPECTROMETRY; MISINCORPORATION; N-(2-AMINOETHYL) GLYCINE;

AMINO ACIDS, DIAMINO; ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BLOOD-BRAIN BARRIER; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXCITATORY AMINO ACID AGONISTS; INJECTIONS, SUBCUTANEOUS; LIVER; MALE; NEUROTOXINS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RATS; TANDEM MASS SPECTROMETRY; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84893857331     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.01.027     Document Type: Article

References (42)

1. Adinolfi M. The development of the human blood-CSF-brain barrier. Dev. Med. Child. Neurol. 1985, 27:532-537.
2. Akaogi J., Barker T., Kuroda Y., Nacionales D.C., Yamasaki Y., Stevens B.R., Reeves W.H., Satoh M. Role of non-protein amino acid l-canavanine in autoimmunity. Autoimmun. Rev. 2006, 5:429-435.
3. Andersson M., Karlsson O., Bergström U., Brittebo E., Brandt I. Maternal transfer of the cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) via milk to suckling offspring. PLoS One 2013, 8:e78133.
4. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1-13.
5. Banack S.A., Murch S.J., Cox P.A. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J. Ethnopharmacol. 2006, 106:97-104.
6. Banack S.A., Metcalf J.S., Jiang L., Craighead D., Ilag L.L., Cox P.A. Cyanobacteria produce N-(2-aminoethyl)glycine, a backbone for peptide nucleic acids which may have been the first genetic molecules for life on Earth. PLoS One 2012, 7:e49043.
7. Bell E.A. Nonprotein amino acids of plants: significance in medicine, nutrition, and agriculture. J. Agric. Food Chem. 2003, 51:2854-2865.
8. Bell E.A. The discovery of BMAA, and examples of biomagnification and protein incorporation involving other non-protein amino acids. Amyotroph. Lateral Scler. 2009, 10(Suppl. 2):21-25.
9. Blomquist L. Mode of accumulation of iodophenylalnines in the exocrine pancreas and certain tumors. Acta Radiol. Suppl. 1972, 332:5-140.
10. Brand L.E., Pablo J., Compton A., Hammerschlag N., Mash D.C. Cyanobacterial blooms and the occurrence of the neurotoxin β-N-methylamino-l-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae 2010, 9:620-635.
11. Chan S.W., Dunlop R.A., Rowe A., Double K.L., Rodgers K.J. L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro. Exp. Neurol. 2012, 238:29-37.
12. Cornford E.M., Cornford M.E. Nutrient transport and the blood-brain barrier in developing animals. Fed. Proc. 1986, 45:2065-2072.
13. Cox P.A., Banack S.A., Murch S.J. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13380-13383.
14. Cox P.A., Banack S.A., Murch S.J., Rasmussen U., Tien G., Bidigare R.R., Metcalf J.S., Morrison L.F., Codd G.A., Bergman B. Diverse taxa of cyanobacteria produce β-N-methylamino-l-alanine, a neurotoxic amino acid. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5074-5078.
15. Dossaji S.F., Bell E.A. Distribution of amino-beta-methylaminopropionic acid in Cycas. Phytochemistry 1973, 12:143-144.
16. Dunlop R.A., Cox P.A., Banack S.A., Rodgers K.J. The non-protein amino acid BMAA is misincorporated into human proteins in place of l-serine causing protein misfolding and aggregation. PLoS One 2013, 8:e75376.
17. Engskog M.K., Karlsson O., Haglof J., Elmsjo A., Brittebo E., Arvidsson T., Pettersson C. The cyanobacterial amino acid β-N-methylamino-l-alanine perturbs the intermediary metabolism in neonatal rats. Toxicology 2013, 312C:6-11.
18. Goto J.J., Koenig J.H., Ikeda K. The physiological effect of ingested β-N-methylamino-l-alanine on a glutamatergic synapse in an in vivo preparation. Comp. Biochem. Physiol. Toxicol. Pharmacol. 2012, 156:171-177.
19. Jiang L., Aigret B., De Borggraeve W.M., Spacil Z., Ilag L.L. Selective LC-MS/MS method for the identification of BMAA from its isomers in biological samples. Anal. Bioanal. Chem. 2012, 403:1719-1730.
20. Jiang L., Johnston E., Aberg K.M., Nilsson U., Ilag L.L. Strategy for quantifying trace levels of BMAA in cyanobacteria by LC/MS/MS. Anal. Bioanal. Chem. 2013, 405:1283-1292.
21. Jiang L., Eriksson J., Lage S., Jonasson S., Shams S., Mehine M., Ilag L.L., Rasmussen U. Diatoms: a novel source for the neurotoxin BMAA in aquatic environments. PLoS One 2014, 9:e84578.
22. Jonasson S., Eriksson J., Berntzon L., Spacil Z., Ilag L.L., Ronnevi L.O., Rasmussen U., Bergman B. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9252-9257.
23. Karlsson O., Berg C., Brittebo E.B., Lindquist N.G. Retention of the cyanobacterial neurotoxin β-N-methylamino-l-alanine in melanin and neuromelanin-containing cells - a possible link between Parkinson-dementia complex and pigmentary retinopathy. Pigm. Cell Melanoma Res. 2009, 22:120-130.
24. Karlsson O., Roman E., Brittebo E.B. Long-term cognitive impairments in adult rats treated neonatally with β-N-methylamino-l-alanine. Toxicol. Sci. 2009, 112:185-195.
25. Karlsson O., Roman E., Berg A.L., Brittebo E.B. Early hippocampal cell death, and late learning and memory deficits in rats exposed to the environmental toxin BMAA (β-N-methylamino-l-alanine) during the neonatal period. Behav. Brain Res. 2011, 219:310-320.
26. Karlsson O., Berg A.L., Lindstrom A.K., Hanrieder J., Arnerup G., Roman E., Bergquist J., Lindquist N.G., Brittebo E.B., Andersson M. Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus. Toxicol. Sci. 2012, 130:391-404.
27. Karlsson O., Bergquist J., Andersson M. Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-l-alanine (BMAA). Mol. Cell. Proteomics 2013, 13:93-104.
28. Karlsson O., Kultima K., Wadensten H., Nilsson A., Roman E., Andren P.E., Brittebo E. Neurotoxin-induced neuropeptide perturbations in striatum of neonatal rats. J. Proteome Res. 2013, 12:1678-1690.
29. Lee J.W., Beebe K., Nangle L.A., Jang J., Longo-Guess C.M., Cook S.A., Davisson M.T., Sundberg J.P., Schimmel P., Ackerman S.L. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006, 443:50-55.
30. 14C-amino acids in mice as determined by whole-body autoradiography: adjunct for radiopharmaceutical synthesis. Int. J. Appl. Radiat. Isot. 1973, 24:705-707.
31. Moreno-Gonzalez I., Soto C. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin. Cell Dev. Biol. 2011, 22:482-487.
32. Murch S.J., Cox P.A., Banack S.A. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12228-12231.
33. Nunn P.B., Bell E.A., Watson A.A., Nash R.J. Toxicity of non-protein amino acids to humans and domestic animals. Nat. Prod. Commun. 2010, 5:485-504.
34. Pablo J., Banack S.A., Cox P.A., Johnson T.E., Papapetropoulos S., Bradley W.G., Buck A., Mash D.C. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol. Scand. 2009, 120:216-225.
35. Rodgers K.J., Shiozawa N. Misincorporation of amino acid analogues into proteins by biosynthesis. Int. J. Biochem. Cell Biol. 2008, 40:1452-1466.
36. Rodgers K.J., Hume P.M., Morris J.G., Dean R.T. Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa. J. Neurochem. 2006, 98:1061-1067.
37. Rubenstein E. Biologic effects of and clinical disorders caused by nonprotein amino acids. Medicine (Baltimore) 2000, 79:80-89.
38. Shahbazian F.M., Jacobs M., Lajtha A. Rates of protein synthesis in brain and other organs. Int. J. Dev. Neurosci. 1987, 5:39-42.
39. Spencer P.S., Nunn P.B., Hugon J., Ludolph A.C., Ross S.M., Roy D.N., Robertson R.C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987, 237:517-522.
40. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc. Pharmacol. 2002, 38:323-337.
41. Xie X., Basile M., Mash D.C. Cerebral uptake and protein incorporation of cyanobacterial toxin β-N-methylamino-l-alanine. Neuroreport 2013, 24:779-784.
42. Zhou X., Escala W., Papapetropoulos S., Bradley W.G., Zhai R.G. BMAA neurotoxicity in Drosophila. Amyotroph. Lateral Scler.: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2009, 10(Suppl. 2):61-66.